Now showing items 1-2 of 2
Selective serotonin reuptake inhibitors (SSRIs) and breast cancer : a record linkage study
Evidence suggests that selective serotonin reuptake inhibitors (SSRIs, a class of antidepressant medications) may contribute to increased breast cancer risk by stimulating the secretion of prolactin, a potential tumour ...
Targeting the actin cytoskeleton in HER2+ metastatic cancer cells using a macrolide toxin
Breast and ovarian cancers are among the leading causes of cancer related deaths in women worldwide. In a subset of these cancers, dysregulation of the human epidermal growth factor receptor 2 (HER2) leads to overexpression ...